Your browser doesn't support javascript.
loading
Effectiveness of Intravenous Isoniazid and Ethambutol Administration in Patients with Tuberculosis Meningoencephalitis and HIV Infection / 결핵
Tuberculosis and Respiratory Diseases ; : 96-103, 2020.
Article in English | WPRIM | ID: wpr-782217
ABSTRACT
BACKGROUND: The aim of this study was to investigate the effectiveness of intravenous isoniazid (H) and ethambutol (E) administered in patients with new sputum positive drug-susceptible pulmonary tuberculosis (TB) with tuberculous meningoencephalitis (TM) and human immunodeficiency virus (HIV) co-infection in the intensive phase of treatment.

METHODS:

Fifty-four patients with TB/TM and HIV co-infection were enrolled for this study. Group 1 comprised of 23 patients treated with E and H intravenously, while rifampicin and pyrazinamide were prescribed orally. Group 2 consisted of 31 patients treated with the first-line anti-TB drugs orally. The concentrations of H and E in blood serum were detected using a chromatographic method.

RESULTS:

A significant improvement in the clinical symptoms and X-ray signs in patients treated intravenously with H and E was observed and compared to group 2. The sputum Mycobacterium tuberculosis positivity was observed during the second month of the treatment in 25.0% of patients from group 1 and 76.1% of the patients from the control group (p=0.003). In addition, nine patients (39.1%) died up to 6 months when H and E were prescribed intravenously compared with 22 (70.9%) in group 2 (p=0.023).

CONCLUSION:

In TB/TM with HIV, the intravenous H and E treatment was more effective than oral H and E treatment at 2 months of intensive treatment in sputum conversion as well as in clinical improvement, accompanied by significantly higher mean serum concentrations. In addition, the mortality rate was lower in intravenous H and E treatment compared to oral treatment.
Subject(s)

Full text: Available Index: WPRIM (Western Pacific) Main subject: Pyrazinamide / Rifampin / Sputum / Tuberculosis / Tuberculosis, Meningeal / Tuberculosis, Pulmonary / HIV Infections / Mortality / HIV / Serum Type of study: Prognostic study Limits: Humans Language: English Journal: Tuberculosis and Respiratory Diseases Year: 2020 Type: Article

Similar

MEDLINE

...
LILACS

LIS

Full text: Available Index: WPRIM (Western Pacific) Main subject: Pyrazinamide / Rifampin / Sputum / Tuberculosis / Tuberculosis, Meningeal / Tuberculosis, Pulmonary / HIV Infections / Mortality / HIV / Serum Type of study: Prognostic study Limits: Humans Language: English Journal: Tuberculosis and Respiratory Diseases Year: 2020 Type: Article